https://www.marketsandmarkets.com/MarketsandMarkets XML Feed en-us Copyright MarketsandMarkets 11/5/2024 2:53:25 PM GMT 11/5/2024 2:53:25 PM GMT 300 https://www.marketsandmarkets.com/ MarketsandMarkets – Market Research Company publishes about 120 business market researchreports a year across 10 main industries. Market research reports and industry trends analysis available from MarketsandMarkets.11/5/2024 2:53:25 PM GMT https://www.marketsandmarkets.com/Market-Reports/freeze-drying-lyophilization-equipment-market-24018886.htmlThe global pharmaceutical drying equipment market growth is primed to transition from USD 5.80 billion in 2024 to USD 8.18 billion by 2029, showcasing a strong CAGR of 7.1%. The expansion of pharmaceutical manufacturing facilities globally, increased demand for biopharmaceuticals such as vaccines, antibodies, and hormones, and the rapid growth of CMOs drive market growth. The market has grown considerably due to the expansion of pharmaceutical manufacturing facilities and the rapid development of CMOs and CDMOs....10/24/2024 GMT https://www.marketsandmarkets.com/Market-Reports/oral-proteins-peptides-market-194705708.htmlThe global oral proteins & peptides market growth is primed to transition from $7.38 billion in 2024 to $20.36 billion by 2029, showcasing a strong CAGR of 22.5%. Market growth is attributed to factors such as the increasing prevalence of chronic diseases (such as diabetes and gastroenterology & kidney diseases), advancements in drug delivery technologies, and patient preference & compliance for the oral route of drug administration. ...10/22/2024 GMT https://www.marketsandmarkets.com/Market-Reports/halal-empty-capsules-market-166042038.htmlThe global halal empty capsules market growth is primed to transition from USD 1.19 billion in 2024 to USD 1.55 billion in 2029, showcasing a strong CAGR of 5.4%. The major factors contributing to the growth of this market include increased adoption of halal-certified and clean label products in emerging and developed countries and the presence of key market players providing halal empty capsules. Furthermore, the launch of new halal-certified products in the market is likely to drive market adoption in the coming years....10/11/2024 GMT https://www.marketsandmarkets.com/Market-Reports/age-related-macular-degeneration-market-37446234.htmlThe global age-related macular degeneration drugs market growth is primed to transition from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, showcasing a strong CAGR of 10.7%. Factors such as the increase in the prevalence of AMD cases due to the changing lifestyle and dietary habits such as smoking, alcohol consumption, and lack of physical activity, a growing focus on research and development highlighted by steady development and approvals of AMD drugs along with improvements in reimbursement policies providing better and affordable access to therapeutic AMD drugs, supports the growth of this market....9/27/2024 GMT https://www.marketsandmarkets.com/Market-Reports/cleanroom-technology-market-263122482.htmlCleanroom technologies market growth is primed to transition from $8.8 billion in 2024 to $12.3 billion by 2029, showcasing a strong CAGR of 6.9%. The rising need for contamination-free environments in the pharmaceutical, medical device, and semiconductor industries drives the growth of cleanroom technologies....9/26/2024 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-contract-manufacturing-market-201524381.htmlThe global pharmaceutical contract manufacturing market growth is primed to transition from USD 200.9 billion in 2024 to USD 319.6 billion in 2029, showcasing a strong CAGR of 9.7%. Increasing use of generic drugs and funding, developments in the field of CMOs technology, the high cost of in-house drug discovery, and regulatory filing by the CMOs drive the growth of this market....8/1/2024 GMT https://www.marketsandmarkets.com/Market-Reports/car-t-cell-therapy-market-47772841.htmlThe global CAR T-cell therapy market growth is primed to transition from USD 5.5 billion in 2024 to USD 29.0 billion by 2029, showcasing a strong CAGR of 39.6%. The growth of this market due to the rise in investments and funding for CAR T-cell therapy developments and technological advancements in CAR T-cell therapy. The growing prevalence of cancer is also expected to support lucrative market growth....7/19/2024 GMT https://www.marketsandmarkets.com/Market-Reports/immunotherapy-drug-market-137717755.htmlThe global immunotherapy drugs market growth is primed to transition from $285.3 billion in 2024 to $580.6 billion by 2029, showcasing a strong CAGR of 15.3%. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies....7/18/2024 GMT https://www.marketsandmarkets.com/Market-Reports/glp-1-analogues-market-218746186.htmlThe size of global GLP-1 analogues market in terms of revenue was estimated to be worth $47.4 billion in 2024 and is poised to reach $471.1 billion by 2032, growing at a CAGR of 33.2% from 2024 to 2032. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics....7/10/2024 GMT https://www.marketsandmarkets.com/Market-Reports/inspection-machines-market-81453085.htmlThe size of global pharmaceutical inspection machines market in terms of revenue was estimated to be worth $0.9 billion in 2024 and is poised to reach $1.4 billion by 2029, growing at a CAGR of 7.6% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics....7/9/2024 GMT https://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.htmlThe global empty capsules market growth is primed to transition from $3.1 billion in 2024 to $4.2 billion by 2029, showcasing a strong CAGR of 6.3%. The growth of the market is driven by technological advancements such as entric coating to protect drugs or nutrients from stomach acids, controlled-release capsules for targeted and sustained drug delivery. ...6/21/2024 GMT https://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.htmlThe global autologous stem cell & non-stem cell therapies market growth is primed to transition from USD 5.5 billion in 2024 to USD 22.2 billion by 2029, showcasing a strong CAGR of 32.3%. The major factors driving the growth of this market are the rising regulatory approvals for autologous CAR T cell therapies, increasing R&D investments in autologous therapeutics, and growing demand for personalized medicines....6/7/2024 GMT https://www.marketsandmarkets.com/Market-Reports/API-Market-263.htmlThe global active pharmaceutical ingredient market growth is primed to transition from USD 163.5 billion in 2024 to USD 238.3 billion by 2029, showcasing a strong CAGR of 7.8%. The major factors driving the growth of this market include the increasing R&D funding, increasing outsourcing of active pharmaceutical ingredients manufacturing services, increase in healthcare expenditure....5/17/2024 GMT https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.htmlThe global vaccines market growth is primed to transition from USD 78.0 billion in 2024 to USD 94.9 billion by 2029, showcasing a strong CAGR of 4.0%. Technological advancements in vaccine development, increasing government initiatives for immunization programs and expanding investments in research and development are some of the factors driving growth of this market....4/24/2024 GMT https://www.marketsandmarkets.com/Market-Reports/fill-finish-manufacturing-market-6249609.htmlThe global fill finish manufacturing market growth is primed to transition from USD 16.7 billion in 2024 to USD 25.7 billion by 2029, showcasing a strong CAGR of 8.9%. The major factors driving the growth of this market include the increasing prevalence of chronic diseases globally is leading to higher production volumes of injectable medications, creating opportunities for fill finish manufacturers to cater to this growing market segment....4/10/2024 GMT https://www.marketsandmarkets.com/Market-Reports/monoclonal-antibody-mabs-therapeutics-market-115323820.htmlThe size of global monoclonal antibody therapeutics market in terms of revenue was estimated to be worth USD 252.6 billion in 2024 and is poised to reach USD 497.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....3/15/2024 GMT https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.htmlThe global theranostics market in terms of revenue was estimated to be worth $2.1 Billion in 2023 and is poised to reach $4.3 Billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....1/22/2024 GMT https://www.marketsandmarkets.com/Market-Reports/contract-research-organization-service-market-167410116.htmlThe global contract research organization services market in terms of revenue was estimated to be worth $82.0 billion in 2024 and is poised to reach $129.8 billion by 2029, growing at a CAGR of 9.6% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....1/11/2024 GMT https://www.marketsandmarkets.com/Market-Reports/antibody-therapeutics-market-178852478.htmlThe size of global antibody therapeutics market in terms of revenue was estimated to be worth USD 247.3 billion in 2023 and is poised to reach USD 479.0 billion by 2028, growing at a CAGR of 14.1% from 2023 to 2028. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....12/4/2023 GMT https://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.htmlThe global pharmaceutical excipients market growth is primed to transition from USD 10.0 billion in 2023 to USD 13.9 billion by 2028, showcasing a strong CAGR of 6.8%. Growth of this market is mainly due to various factors such as growing emphasis on patient-centric formulations, increasing demand for generic drugs and pharmaceutical products, increased R&D Investments for the development of novel excipients and collaborations and partnerships with pharmaceutical companies for customized excipient solutions....11/29/2023 GMT https://www.marketsandmarkets.com/Market-Reports/continuous-bioprocessing-market-75067818.htmlThe global continuous bioprocessing market growth is primed to transition from USD 218 million in 2023 to USD 599 million by 2028, showcasing a strong CAGR of 22.4%. The growth of the market is largely driven by rising demand for biopharmaceuticals, advantages of continuous bioprocessing over batch/fed-batch mode, and emergence of integrated end-to-end continuous bioprocessing....11/22/2023 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.htmlThe global pharmaceutical packaging equipment market in terms of revenue was estimated to be worth $8.9 billion in 2023 and is poised to reach $12.4 billion by 2028, growing at a CAGR of 7.0% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....10/12/2023 GMT https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.htmlThe global clinical trial supplies market in terms of revenue was estimated to be worth $3.9 billion in 2023 and is poised to reach $6.3 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....10/9/2023 GMT https://www.marketsandmarkets.com/Market-Reports/cardiac-safety-services-market-174488627.htmlCardiac safety services market is primed to transition from $739 million in 2023 to 1,282 million by 2028, showcasing a strong CAGR of 11.6%. This growth is largely driven by the increasing prevalence of cardiovascular diseases, which raises the demand for cardiac safety assessments by pharmaceutical companies and contract research organizations (CROs). However, the market faces challenges such as inadequate cardiotoxicity testing and high costs associated with safety evaluations. Opportunities are arising from advancements in detection methods, including digital twin technology and non-invasive imaging. North America is poised to lead the market, thanks to its robust pharmaceutical industry and extensive clinical trial activities. Key players in the market include Laboratory Corporation of America Holdings, Medpace, and IQVIA....10/3/2023 GMT https://www.marketsandmarkets.com/Market-Reports/softgel-capsules-market-238329912.htmlThe global softgel capsules market growth is primed to transition from $1.1 billion in 2023 to $1.5 billion by 2028, showcasing a strong CAGR of 6.3%. The growth of this market is majorly driven by the benefits of softgel capsules, increasing demand for dietary supplements and nutraceuticals, and rising demand for naturally sourced ingredients. On the other hand, limited acceptance due to cultural restrictions is expected to hinder the growth of this market....9/29/2023 GMT https://www.marketsandmarkets.com/Market-Reports/clinical-trials-market-405.htmlThe global clinical trials market in terms of revenue was estimated to be worth $48.2 billion in 2023 and is poised to reach $73.2 billion by 2028, growing at a CAGR of 8.7% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....9/8/2023 GMT https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.htmlThe global veterinary API market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $11.9 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....6/20/2023 GMT https://www.marketsandmarkets.com/Market-Reports/biosimilars-40.htmlBiosimilars market growth is primed to transition from 29.4 billion in 2023 to USD 66.9 billion by 2028, showcasing a strong CAGR of 17.8%. This market is driven by increasing demand for cost-effective treatments amidst rising chronic disease rates and the patent expirations of major biologics. Key trends include the rapid approval and adoption of biosimilars, particularly in oncology. ...6/7/2023 GMT https://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.htmlThe global nuclear medicine market growth is primed to transition from USD 5.5 billion in 2023 to USD 9.4 billion by 2028, showcasing a strong CAGR of 11.3%. Market growth in this market are driven by the factors such as the technology advancement in radioisotope production and rising occurrence of cancer and CVD....5/4/2023 GMT https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.htmlThe global veterinary vaccines market in terms of revenue was estimated to be worth $8.1 billion in 2022 and is poised to reach $10.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....4/5/2023 GMT https://www.marketsandmarkets.com/Market-Reports/animal-parasiticide-market-258895412.htmlThe global animal parasiticides market in terms of revenue was estimated to be worth $10.6 billion in 2022 and is poised to reach $14.1 billion by 2027, growing at a CAGR of 5.8% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....3/28/2023 GMT https://www.marketsandmarkets.com/Market-Reports/drug-discovery-services-market-138732129.htmlThe global drug discovery services market growth is primed to transition from USD 20.7 billion in 2024 to USD 41.4 billion by 2028, showcasing a strong CAGR of 14.9%....3/20/2023 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-gelatin-market-21807555.htmlThe global pharmaceutical gelatin market growth is primed to transition from $1.1 billion in 2022 to $1.5 billion by 2027, showcasing a strong CAGR of 5.5%. Growth of this market is attributable to various factors such as rising demand for pharma gelatin in vaccines, tablets, and other applications. Furthermore, the launch of the novel, technologically advanced, and user-friendly pharma gelatin is likely to increase global demand. ...12/5/2022 GMT https://www.marketsandmarkets.com/Market-Reports/single-use-consumable-market-44374840.htmlThe size of global single use consumables market in terms of revenue was estimated to be worth USD 2.2 billion in 2022 and is poised to reach USD 4.7 billion by 2027, growing at a CAGR of 16.6% from 2022 to 2027. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics....10/27/2022 GMT https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-formulas-market-74876393.htmlThe global enteral feeding formulas market growth is primed to transition from $5.2 billion in 2022 to $8.2 billion by 2027, showcasing a strong CAGR of 9.5%. Factors such as rising healthcare expenditure; a surge in the number of preterm births worldwide; growing aging population in need for enteral feeding; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition benefits; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period....8/5/2022 GMT https://www.marketsandmarkets.com/Market-Reports/overactive-bladder-treatment-market-219938791.htmlThe size of global overactive bladder treatment market in terms of revenue was estimated to be worth USD 3.5 billion in 2022 and is poised to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....7/4/2022 GMT https://www.marketsandmarkets.com/Market-Reports/topical-drug-delivery-market-124871717.htmlThe global topical drug delivery market in terms of revenue was estimated to be worth USD 207.4 billion in 2022 and is poised to reach USD 317.8 billion by 2027, growing at a CAGR of 8.9% from 2022 to 2027. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics....5/25/2022 GMT https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market-36582475.htmlThe global high potency APIs market growth is primed to transition from $24.5 billion in 2022 to $39.6 billion by 2027, showcasing a strong CAGR of 10.1%. This growth is driven by increasing demand for oncology drugs, advancements in HPAPI manufacturing technologies, and the rising focus on precision medicine....5/17/2022 GMT https://www.marketsandmarkets.com/Market-Reports/prostate-health-market-107055093.htmlThe global prostate health market growth is primed to transition from USD 31.8 billion in 2021 to USD 48.9 billion by 2026, showcasing a strong CAGR of 9.0%. Growth in this market is primarily driven by the increasing prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in prostate health, an increase in the prevalence of prostate cancer, a surge in demand for hormone therapy drugs, emerging therapies for prostate cancer, and an increasing incidence of prostatitis....12/9/2021 GMT https://www.marketsandmarkets.com/Market-Reports/ear-health-market-203353767.htmlThe ear health market is expected to grow from USD 1.4 billion in 2021 to USD 1.9 billion by 2026, at a compound annual growth rate (CAGR) of 6.3% during the forecast period. The prominent players Sonova Holdings AG (Switzerland), Olympus Corp. (Japan), William Demant Holdings A/S (Denmark), Cochlear Limited (Australia), Stryker Corporation (US), Johnson & Johnson (US), Novartis (Switzerland), Karl Storz GMBH & Co. KG (Germany), Medtronic Plc (Ireland), Oscar Remedies Pvt Ltd. (India), and InnerScope Hearing Technologies (US)....12/7/2021 GMT https://www.marketsandmarkets.com/Market-Reports/animal-antimicrobials-antibiotics-market-25161353.htmlThe global animal antibiotics market growth is primed to transition from $4.7 billion in 2021 to $5.6 billion by 2026, showcasing a strong CAGR of 3.6%. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases....3/4/2021 GMT https://www.marketsandmarkets.com/Market-Reports/tablet-coatings-market-150774403.htmlThe size of global tablet coatings market in terms of revenue was estimated to be worth USD 739 million in 2020 and is poised to reach USD 969 million by 2025, growing at a CAGR of 5.6% from 2020 to 2025. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics....2/25/2021 GMT https://www.marketsandmarkets.com/Market-Reports/anesthesia-drugs-ketamine-market-713.htmlThe global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....2/3/2021 GMT https://www.marketsandmarkets.com/Market-Reports/osteoarthritis-therapeutics-market-209565994.htmlThe global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%. ...12/11/2020 GMT https://www.marketsandmarkets.com/Market-Reports/asia-pacific-animal-health-market-106215485.htmlThe global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....11/25/2020 GMT https://www.marketsandmarkets.com/Market-Reports/covid-19-impact-on-vaccines-market-112248051.htmlThe COVID-19 vaccines & drugs market is expected to grow from USD 2,273 million in 2022 to USD 1,401 million by 2025 at a compound annual growth rate (CAGR) of 14.9% during the forecast period.Key players in the COVID-19 vaccines market include Pfizer Inc. (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc. (UK), Sanofi (France) Serum Institute of India (India), among others. Major players in the COVID-19 drugs market include Gilead Sciences, Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), Janssen Pharmaceuticals, Inc. (Belgium) among others....5/4/2020 GMT https://www.marketsandmarkets.com/Market-Reports/north-american-nuclear-medicine-radiopharmaceuticals-market-1108.htmlNorth american nuclear medicine market growth is primed to transition from $2.2 billion in 2019 to $2.7 billion by 2024, showcasing a strong CAGR of 4.1%. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent....1/22/2020 GMT https://www.marketsandmarkets.com/Market-Reports/womens-health-care-market-136585329.htmlThe global women's healthcare market growth is primed to transition from $9.6 billion in 2019 to $17.8 billion by 2024, showcasing a strong CAGR of 13.2%. Key drivers of this growth include increasing chronic health conditions among women, government initiatives for population control, and rising demand for contraceptives....1/16/2020 GMT https://www.marketsandmarkets.com/Market-Reports/stable-isotope-labeling-market-53034199.htmlThe global stable isotope labeled compounds market in terms of revenue was estimated to be worth $269 million in 2019 and is poised to reach $312 million by 2024, growing at a CAGR of 3.0% from 2019 to 2024. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market....1/10/2020 GMT https://www.marketsandmarkets.com/Market-Reports/bioprocess-validation-market-39981433.htmlThe global bioprocess validation market size is projected to reach USD 360 million by 2024, at a CAGR of 14.6%. The prominent players operating in this market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US)....7/30/2019 GMT